Role of metallothionein in 4-aminopyrazolo[3,4-d]pyrimidine-administered mouse pancreas.
Pancreatic metallothionein (MT) and zinc levels were measured after the administration of 4-aminopyrazolo(3,4-d)pyrimidine (4APP) to mice to determine the role of pancreatic MT. 4APP was found to increase the pancreatic MT level dose-dependently; the pancreatic MT level in mice administered 175 mg/kg of 4APP was 3.9 fold higher than that in control mice. When 40 mg/kg or less of 4APP was administered, the zinc concentration of the pancreatic cytosol fraction did not differ from that in control mice, while after 175 mg/kg of 4APP it was 1.7-fold higher. There was no difference in plasma glucose and insulin levels between the controls and mice administered 175 mg/kg of 4APP, although the plasma alpha-amylase activity was reduced in the latter. Moreover, a linear negative relationship was observed between pancreatic MT level and plasma alpha-amylase activity (r = -0.795, p < 0.01). These findings suggest that pancreatic MT is affected by the disruption of the exocrine function in 4APP-administered mouse pancreas.
Minami
T
T
Faculty of Pharmaceutical Sciences, Kinki University, Osaka, Japan.
Nakagawa
H
H
Yoshimoto
S
S
Asano
I
I
Okazaki
Y
Y
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007328:Insulin / Q000097:blood; D008297:Male; D008668:Metallothionein / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism; D015032:Zinc / Q000378:metabolism*; D000516:alpha-Amylases / Q000097:blood
D000924:Anticholesteremic Agents; D007328:Insulin; C004420:4-aminopyrazolo(3,4-d)pyrimidine; D008668:Metallothionein; D000516:alpha-Amylases; D015032:Zinc; D000225:Adenine